These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1323594)

  • 1. The use of antimycobacterial agents in Crohn's disease.
    Thayer WR
    J Clin Gastroenterol; 1992 Jul; 15(1):5-7. PubMed ID: 1323594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
    Selby W; Pavli P; Crotty B; Florin T; Radford-Smith G; Gibson P; Mitchell B; Connell W; Read R; Merrett M; Ee H; Hetzel D;
    Gastroenterology; 2007 Jun; 132(7):2313-9. PubMed ID: 17570206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evidence for Mycobacterium paratuberculosis in Crohn's disease.
    Behr MA; Kapur V
    Curr Opin Gastroenterol; 2008 Jan; 24(1):17-21. PubMed ID: 18043227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifabutin and ethambutol do not help recurrent Crohn's disease in the neoterminal ileum.
    Rutgeerts P; Geboes K; Vantrappen G; Van Isveldt J; Peeters M; Penninckx F; Hiele M
    J Clin Gastroenterol; 1992 Jul; 15(1):24-8. PubMed ID: 1323593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium paratuberculosis and Mycobacterium avium subsp. silvaticum DNA cannot be detected by PCR in Crohn's disease tissue.
    Cellier C; De Beenhouwer H; Berger A; Penna C; Carbonnel F; Parc R; Cugnenc PH; Le Quintrec Y; Gendre JP; Barbier JP; Portaels F
    Gastroenterol Clin Biol; 1998; 22(8-9):675-8. PubMed ID: 9823555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen.
    Prantera C; Kohn A; Mangiarotti R; Andreoli A; Luzi C
    Am J Gastroenterol; 1994 Apr; 89(4):513-8. PubMed ID: 8147352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimycobacterial therapy in Crohn's disease: game over?
    Peyrin-Biroulet L; Neut C; Colombel JF
    Gastroenterology; 2007 Jun; 132(7):2594-8. PubMed ID: 17570230
    [No Abstract]   [Full Text] [Related]  

  • 8. The causation of Crohn's disease and treatment with antimicrobial drugs.
    Hermon-Taylor J
    Ital J Gastroenterol Hepatol; 1998 Dec; 30(6):607-10. PubMed ID: 10076782
    [No Abstract]   [Full Text] [Related]  

  • 9. Importance of the Australian Crohn's disease antibiotic study.
    Chamberlin W
    Gastroenterology; 2007 Nov; 133(5):1744-5; author reply 1745-6. PubMed ID: 17983827
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection and Isolation of Mycobacterium avium subspecies paratuberculosis from intestinal mucosal biopsies of patients with and without Crohn's disease in Sardinia.
    Sechi LA; Scanu AM; Molicotti P; Cannas S; Mura M; Dettori G; Fadda G; Zanetti S
    Am J Gastroenterol; 2005 Jul; 100(7):1529-36. PubMed ID: 15984976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Paratuberculose enteritis and Crohn's disease].
    Suárez Fernández G
    An R Acad Nac Med (Madr); 2007; 124(2):221-34; discussion 234-40. PubMed ID: 18069597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Australian antibiotic trial in Crohn's disease: alternative conclusions from the same study.
    Kuenstner JT
    Gastroenterology; 2007 Nov; 133(5):1742-3; author reply 1745-6. PubMed ID: 17983824
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure?
    Borody TJ; Leis S; Warren EF; Surace R
    Dig Liver Dis; 2002 Jan; 34(1):29-38. PubMed ID: 11926571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium avium subspecies paratuberculosis and Crohn's disease granulomas.
    Toracchio S; El-Zimaity HM; Urmacher C; Katz S; Graham DY
    Scand J Gastroenterol; 2008; 43(9):1108-11. PubMed ID: 18609156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Australian Crohn's antibiotic study opens new horizons.
    Gitlin L; Biesecker J
    Gastroenterology; 2007 Nov; 133(5):1743-4; author reply 1745-6. PubMed ID: 17983826
    [No Abstract]   [Full Text] [Related]  

  • 16. Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease.
    Shafran I; Kugler L; El-Zaatari FA; Naser SA; Sandoval J
    Dig Liver Dis; 2002 Jan; 34(1):22-8. PubMed ID: 11930899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-mycobacterial therapy in Crohn's disease heals mucosa with longitudinal scars.
    Borody TJ; Bilkey S; Wettstein AR; Leis S; Pang G; Tye S
    Dig Liver Dis; 2007 May; 39(5):438-44. PubMed ID: 17369114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The etiology of Mycobacterium avium subspecies paratuberculosis in Crohn's disease.
    Alluwaimi AM
    Saudi Med J; 2007 Oct; 28(10):1479-84. PubMed ID: 17914503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics and probiotics in inflammatory bowel disease: why, when, and how.
    Prantera C; Scribano ML
    Curr Opin Gastroenterol; 2009 Jul; 25(4):329-33. PubMed ID: 19444096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.